We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 289 results
  1. Long term follow-up after haematopoietic stem cell transplantation for mucopolysaccharidosis type I-H: a retrospective study of 51 patients

    Mucopolysaccharidosis type I-H (MPS I-H) is a rare lysosomal storage disorder caused by α-L-Iduronidase deficiency. Early haematopoietic stem cell...

    Antoine Gardin, Martin Castelle, ... Anaïs Brassier in Bone Marrow Transplantation
    Article Open access 09 December 2022
  2. Bedeutung lysosomaler Speicherkrankheiten in der Rheumatologie

    Lysosomal storage diseases are a group of rare hereditary metabolic diseases. Due to a deficiency of lysosomal enzymes, complex substrates accumulate...

    Charlotte Aries, Cornelia Rudolph, Nicole Muschol in Zeitschrift für Rheumatologie
    Article 27 May 2024
  3. Safety outcomes and patients’ preferences for home-based intravenous enzyme replacement therapy (ERT) in pompe disease and mucopolysaccharidosis type I (MPS I) disorder: COVID-19 and beyond

    Background

    The Italian Medicines Agency (AIFA) demands precise information on benefit/risk profile of home-based enzyme replacement therapy (ERT) for...

    Antonio Toscano, Olimpia Musumeci, ... Maurizio Scarpa in Orphanet Journal of Rare Diseases
    Article Open access 27 October 2023
  4. An uplifted destiny for mucopolysaccharidosis type I with heart valve involvement

    Raffaele Manna, Francesca Graziani, ... Donato Rigante in Internal and Emergency Medicine
    Article 24 April 2021
  5. Application of tandem mass spectrometry in the screening and diagnosis of mucopolysaccharidoses

    Mucopolysaccharidoses (MPSs) are caused by a deficiency in the enzymes needed to degrade glycosaminoglycans (GAGs) in the lysosome. The storage of...

    **g-Wen Li, Shao-Jia Mao, ... Chao-Chun Zou in Orphanet Journal of Rare Diseases
    Article Open access 29 April 2024
  6. Screening for lysosomal diseases in a selected pediatric population: the case of Gaucher disease and acid sphingomyelinase deficiency

    Background

    GD and ASMD are lysosomal storage disorders that enter into differential diagnosis due to the possible overlap in their clinical...

    Maja Di Rocco, Carlo Dionisi Vici, ... Andrea Pession in Orphanet Journal of Rare Diseases
    Article Open access 21 July 2023
  7. Establishing a core outcome set for mucopolysaccharidoses (MPS) in children: study protocol for a rapid literature review, candidate outcomes survey, and Delphi surveys

    Background

    Mucopolysaccharidoses (MPS) are a group of inherited metabolic diseases characterized by chronic, progressive multi-system manifestations...

    Alison H. Howie, Kylie Tingley, ... Beth K. Potter in Trials
    Article Open access 17 November 2021
  8. Dry synovitis, a rare entity distinct from juvenile idiopathic arthritis

    Background

    Dry synovitis (DS) is a rare entity as only a few cases have been reported to date. We describe the clinical features, radiological...

    Lien De Somer, Brigitte Bader-Meunier, ... Francesco Zulian in Pediatric Rheumatology
    Article Open access 23 January 2023
  9. Neue Therapien bei lysosomalen Speicherkrankheiten

    Nicole Muschol, Charlotte Aries in Pädiatrie & Pädologie
    Article 28 September 2021
  10. Multimodal imaging of Hurler syndrome-related keratopathy treated with deep anterior lamellar keratoplasty

    Background

    Hurler syndrome-associated keratopathy is an exceedingly rare corneal disorder that requires corneal transplantation in advanced stages....

    Elodie Da Cunha, Cristina Georgeon, ... Vincent M. Borderie in BMC Ophthalmology
    Article Open access 31 October 2020
  11. Classifying vertebral artery anatomy abnormality in children with skeletal dysplasia

    Purpose

    Skeletal dysplasia (SKD) have predictably abnormal occipitocervical skeletal anatomy, but a similar understanding of their vertebral artery...

    Jennifer M. Bauer, Ekamjeet S. Dhillon, ... Klane K. White in Spine Deformity
    Article 05 January 2021
  12. Enzymtherapien in der Neurologie

    As with many other rare diseases, the diagnosis of congenital metabolic disorders is much faster and easier with modern genetic testing methods. The...

    Fritz Zimprich in psychopraxis. neuropraxis
    Article 18 September 2020
  13. Molecular environment and atypical function: What do we know about enzymes associated with Mucopolysaccharidoses?

    Mucopolysaccharidoses are a group of lysosomal storage disorders caused by deficiency of enzymes involved in glycosaminoglycans degradation....

    Wei**g Kong, Cheng Lu, ... Yan Meng in Orphanet Journal of Rare Diseases
    Article Open access 04 March 2022
  14. In search of causal pathways in diabetes: a study using proteomics and genoty** data from a cross-sectional study

    Aims/hypothesis

    The pathogenesis of type 2 diabetes is not fully understood. We investigated whether circulating levels of preselected proteins were...

    Kristina Beijer, Christoph Nowak, ... Lars Lind in Diabetologia
    Article Open access 24 August 2019
  15. Die Grenzen der Enzymersatztherapien sprengen

    Nicole Muschol, Charlotte Aries in Pädiatrie
    Article 15 April 2021
  16. Technologies of gene editing and related clinical trials for the treatment of genetic and acquired diseases: a systematic review

    Background

    Gene editing can produce irreversible permanent changes to the genetic material at predetermined sequences, avoiding random integration,...

    Article Open access 07 March 2024
  17. Clinical and radiological findings in Brazilian patients with mucolipidosis types II/III

    Objective

    The present study aims to provide orientation for clinicians and radiologists to recognize the most prevalent findings leading to diagnosis...

    José Ricardo Magliocco Ceroni, Gustavo Marquezani Spolador, ... Chong Ae Kim in Skeletal Radiology
    Article 02 February 2019
  18. Valvular heart disease and cardiomyopathy: reappraisal of their interplay

    Cardiomyopathies and valvular heart diseases are typically considered distinct diagnostic categories with dedicated guidelines for their management....

    Nina Ajmone Marsan, Francesca Graziani, ... Filippo Crea in Nature Reviews Cardiology
    Article 10 August 2023
  19. Novel approach to idursulfase and laronidase desensitization in type 2 and type 1 S mucopolysaccharidosis (MPS)

    Background:

    Idursulfase and laronidase are drugs used to treat Hunter syndrome (mucopolysaccharidosis type 2) and Scheie syndrome...

    Federico Spataro, Fabio Viggiani, ... Luigi Macchia in Orphanet Journal of Rare Diseases
    Article Open access 03 November 2022
  20. Mechanisms of Neutralizing Anti-drug Antibody Formation and Clinical Relevance on Therapeutic Efficacy of Enzyme Replacement Therapies in Fabry Disease

    Fabry disease (FD) is a rare X-linked lysosomal storage disorder caused by mutations in the α-galactosidase A (AGAL/GLA) gene. The lysosomal...

    Malte Lenders, Eva Brand in Drugs
    Article Open access 08 November 2021
Did you find what you were looking for? Share feedback.